Print

Speakers

Monica Alves

Monica Alves, MD, PhD
Professor of Ophthalmology
University of Campinas
Brazil

Monica Alves is currently a professor of ophthalmology at University of Campinas, Brazil. She earned her MD from the Federal University of Juiz de Fora and her PhD at University of Campinas. She was a post-doctoral fellow at the University of São Paulo, in clinical studies of dry eye and ocular surface. She dedicates her research program to better understand dry eye and ocular surface  diseases, epidemiology, clinical challenges and related mechanisms.

William Brunken

William J. Brunken, PhD
Professor and Vice Chair, Ophthalmology & Visual Sciences
Professor, Neuroscience & Physiology
Upstate Medical University
Syracuse, N.Y.

William Brunken received his doctoral degree from Stony Brook University and performed post-doctoral studies at Washington University in Saint Louis.  Before joining Upstate Medical University, Brunken served on the faculties at Boston College, Tufts University School of Medicine and SUNY Downstate Medical Center. His early work focused on the neural chemical organization of the retina, with particular focus on indoleamine signaling.  More recently, his laboratory has been studying the role of the extracellular matrix in retinal development with the goal to translate their findings translational gains including the engineering of stem cells, integration of electronic neural prostheses, and regulation of neovascularization.

Julia Busik

Julia Busik, PhD
Professor of Physiology
Michigan State University
East Lansing, Mich.

Julia Busik is professor of physiology at Michigan State University. She received her BS and MS degrees from Novosibirsk State University, USSR, and her PhD from the Graduate University for Advanced Studies, Department of Physiology, Yokohama, Japan. Busik started research in the area of diabetic complications after joining Michigan State University as a post-doctoral fellow under the guidance of Douglas Henry. Busik has received the Carrier Development Award from the Juvenile Diabetes Research Foundation and numerous research awards from the National Eye Institute and American Diabetes Association, among other honors.

Michelle Callegan

Michelle C. Callegan, PhD
Director of Vision Research, Dean A. McGee Eye Institute
University of Oklahoma Health Sciences Center
Oklahoma City, Okla.

Michelle C. Callegan is the director of Vision Research at the Dean A. McGee Eye Institute, a Dean A. McGee Endowed Professor of Ophthalmology, an Edith Kinney Gaylord Presidential Professor and a George Lynn Cross Research Professor at the University of Oklahoma Health Sciences Center in Oklahoma City. Callegan received her PhD at the Louisiana State University Medical Center in New Orleans, La. Her research interests include the molecular pathogenesis of and novel therapeutics for the treatment of bacterial ocular infections.

Matilda Chan

Matilda Chan, MD, PhD
Associate Professor, Ophthalmology
Francis I. Proctor Foundation
University of California San Francisco
San Francisco, Calif.

Matilda Chan is an associate professor in the Department of Ophthalmology and the Francis I. Proctor Foundation at the University of California San Francisco. She received her undergraduate degree from the University of California, Berkeley and her MD/PhD degrees from the Keck School of Medicine at the University of Southern California. She completed her ophthalmology residency at the Flaum Eye Institute of the University of Rochester, which was followed by a fellowship in cornea and external diseases at the Francis I. Proctor Foundation at the University of California San Francisco. Her clinical expertise is the diagnosis and management of patients with corneal and ocular surface diseases. Her basic/translational research program focuses on molecular mechanisms related to corneal repair and corneal endothelial dystrophies.

Emily Chew

Emily Chew, MD
Director of the Division of Epidemiology and Clinical Applications
Chief of the Clinical Trails Branch
National Eye Institute, National Institutes of Health
Bethesda, Md.

Emily Chew is the Director of the Division of Epidemiology and Clinical Applications (DECA) at the National Eye Institute, National Institutes of Health in Bethesda, Md. She is also the chief of the Clinical Trials Branch in the division. Chew received her medical degree and her ophthalmology training at the University of Toronto, Canada. She completed her fellowship in medical retina at the Wilmer Eye Institute, the Johns Hopkins Medical Institutes and the University of Nijmegen, the Netherlands. Her research interest includes phase I/II and phase III clinical trials and epidemiologic studies in retinovascular diseases such as age-related macular degeneration, diabetic retinopathy and other ocular diseases.

Zelia Correa

Zelia Correa, MD, PhD
Co-Director, Ocular Oncology Service
Professor, Ophthalmology
Bascom Palmer Eye Institute, Sylvester Comprehensive Cancer Center
University of Miami
Miami, Fla.

Zelia Correa is the co-director of the Ocular Oncology Service and a professor of ophthalmology at the Bascom Palmer Eye Institute, Sylvester Comprehensive Cancer Center, University of Miami. Her clinical practice focuses on patients with ocular and systemic cancers with ocular manifestations. Her research interests include uveal melanoma and retinoblastoma.

Patricia D'Amore

Patricia D'Amore, PhD, MBA
Charles L. Schepens Professor of Ophthalmology
Professor of Pathology
Vice-chair of Basic and Translational Research, Dept of Ophthalmology 
Harvard Medical School
Associate Chief of Basic and Translational Research, Ophthalmology
Massachusetts Eye and Ear 
Boston, Mass.

Patricia A. D’Amore received a PhD in biology from Boston University in 1977. She conducted postdoctoral research in the Departments of Ophthalmology Physiological Chemistry at Johns Hopkins University School of Medicine. In 1998 she was appointed professor of ophthalmology and in 2014 professor of pathology at Harvard Medical School. She is also the associate chief for Ophthalmology Basic and Translational Research for Ophthalmology at Massachusetts Eye and Ear and the vice chair of Basic and Translational Research for the Department of Ophthalmology at Harvard Medical School. Her current research focuses on understanding the role of the endothelial glycocalyx in the regulation of microvascular proliferation and vascular inflammation. She is also investigating the pathogenesis of age-related macular degeneration with a focus on the role of lipids.

Cintia de Paiva

Cintia de Paiva, MD, PhD
Associate Professor, Ophthalmology
Baylor College of Medicine
Houston, Tex.

Cintia de Paiva is associate professor of ophthalmology, Baylor College of Medicine in Houston, Tex. She received her MD from State University of Campinas-UNICAMP in Sao Paulo, Brazil and her PhD from University of Sao Paulo, Ribeirao Preto. Her research interests include dry eye, ocular surface siseases, animal models of Sjogren Syndrome, microbiome and aging. The primary objectives of her  research are to investigate the pathogenesis of dry eye-related diseases with the ultimate goal to improve the diagnosis, prognosis and therapy of dry eye.

Lynn Gordon

Lynn Gordon, MD, PhD
Professor Emeritus, Ophthalmology
Stein Eye Institute
University of California
Los Angeles, Calif.

Lynn K Gordon is professor emeritus of ophthalmology at the Stein Eye Institute at UCLA and was the inaugural Senior Associate Dean for Equity and Diversity Inclusion at the David Geffen School of Medicine at UCLA. Following her undergraduate training at Stanford University, she completed both her MD and PhD at Harvard University, and residency in ophthalmology and fellowship training in neuro-ophthalmology at UCLA. She is an active clinician scientist whose work has resulted in multiple patents and more than 100 publications, book chapters, and reviews. She serves on the editorial boards for Ophthalmology Retina, Journal of Neuro-ophthalmology and the Journal of Ocular Immunology and Inflammation. Gordon has held leadership positions in several state and national professional organizations, including being a current member of the board of the North American Neuro-Ophthalmology Society, past president of the California Academy of Eye Physicians and Surgeons, former member of the Board of Trustees and past Chair of the Council of the American Academy of Ophthalmology. She helped create multiple faculty development and leadership programs at UCLA, as well as through organizations. Her greatest passion is helping individuals realize their full potential.

Jarrod Harman

Jarrod Harman, PhD candidate
Doctor of Philosophy, Biochemistry & Molecular Biology
PhD Candidate
Lousiana State University Health Sciences Center
New Orleans, La.

Jarrod Harman is preparing for his PhD defense (scheduled in March) at Louisiana State University Health Sciences Center (LSUHSC), New Orleans, La. Harman began engaging in advocacy as a student government representative for LSUHSC at Louisiana Board of Regents meetings. As a 2019 ARVO Science Communication Training Fellow, he participated in ARVO's Advocacy Day in Washington, D.C., to advocate for funding for the National Eye Institute and used his own research to articulate the return-on-investment of federal funding. Harman was named the first recipient of ARVO’s Emerging Advocate Award.

Lyndon Jones

Lyndon Jones, PhD, FCOptom
Professor & Director, Centre for Ocular Research & Education
University Research Chair, Adjunct Professor
University of Waterloo
WaterlooONCanada

Lyndon Jones graduated in optometry from the University of Wales in 1985 and gained his PhD in chemical engineering from the Biomaterials Research Unit at Aston University, Birmingham, UK in 1998. He was also awarded an Honorary DSc by Aston in 2018. Jones received the Fellowship of the Canadian Academy of Health Sciences (CAHS) in 2017. His research interests primarily focus on the interaction of novel and existing contact lens materials with the ocular environment, dry eye and ocular drug delivery.

Jennifer Kang-Mieler

Jennifer J. Kang-Mieler, PhD, FARVO
Professor, Biomedical Engineering
Illinois Institute of Technology
Chicago, Ill.

Jennifer J. Kang-Mieler is a professor of biomedical engineering at the Illinois Institute of Technology, Chicago, Ill.  She received her BA in mathematics, MS in applied mathematics and PhD in biomedical engineering from the Northwestern University.  She completed post-doctoral fellowship at the University of Illinois at Chicago in the Department of Ophthalmology and Visual Sciences. Kang-Mieler’s translational research interests include ocular drug delivery, nitric oxide sensor development, retinal imaging, retinal blood flow and modeling. She is an active member of the Macula Society, the Retina Society, the American Society of Retina Specialists (ASRS), the Association for Research in Vision and Ophthalmology (ARVO), the Biomedical Engineering Society (BMES), Asia-Pacific Academy of Ophthalmology (APAO) and the Dowling Society.  As an active ARVO member, Kang-Mieler has served on the Board of Trustees and the AMPC, representing the Retina Section.  She also served as the vice president of ARVO and is currently co-chair of the Global Mentorship Program.

Aparna Lakkaraju

Aparna Lakkaraju, PhD
Associate Professor, Department of Ophthalmology
University of California, San Francisco
San Francisco, Calif.

Aparna Lakkaraju is an associate professor in the Department of Ophthalmology at the University of California, San Francisco. Lakkaraju and her team have pioneered high-speed, high-resolution live-cell imaging to identify functional deficits in the retinal pigment epithelium (RPE), a technique they have now extended to the living retina. Her group discovered novel mechanisms centered around membrane dynamics and intracellular trafficking that could modulate multiple homeostatic pathways in the RPE. These studies helped identify FDA-approved drugs that efficiently upregulate autophagy and prevent complement-induced inflammation, two pathways implicated driving vision loss in inherited and age-related macular degenerations.

Vinit Mahajan

Vinit Mahajan, MD, PhD
Associate Professor
Vitreoretinal Surgeon and Scientist
Department of Ophthalmology
Stanford University
Stanford, Calif.

Vinit Mahajan is an associate professor and vitreoretinal surgeon and scientist in the Department of Ophthalmology at Stanford University. He directs the NIH-funded Omics Laboratory that uses high-throughput methods in genomics, proteomics, and phenomics to identify molecules involved in vitreoretinal disease. Dr. Mahajan earned his bachelor’s degree in Molecular and Cell Biology at the University of California, Berkeley. He then entered the Medical Scientist Training Program at the University of California, Irvine. Upon completion, he joined the residency program at the Jules Stein Eye Institute at the University of California, Los Angeles. At UCLA he completed post doctoral laboratory research as an EyeSTAR Fellow. He next specialized in vitreoretinal diseases and surgery at the University of Iowa’s Retina Fellowship Program.

Juan Carlos Gil Munoz

Juan Carlos Gil Muñoz, MD
Ophthalmolgy Specialist
Universidad CES
Medellin, Colombia

Juan Carlos Gil Muñoz is an ophthalmology specialist from Universidad CES - Medellin / Colombia. His received his MsC anterior segments surgery and pathology from Instituto Barraquer Barcelona and Universidad de Cataluña. He is also an epidemiologist from Universidad CES. He has served as editor-in-chief of the Colombian Journal of Ophthalmology (Revista SCO) as well as professor and research leader in ophthalmology faculty at Universidad CES and residency program.

Machelle Pardue

Machelle Pardue, PhD, FARVO, FAIMBE
Senior Research Career Scientist, Atlanta VA Medical Center
Professor and Associate Chair of Faculty Development, Georgia Institute of Technology
Executive Associate Director of Atlanta VA Center for Visual and Neurocognitive Rehabilitation
Atlanta,Ga.

Machelle Pardue is a senior research career scientist at the Atlanta VA Medical Center, and a professor and associate chair in Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University School of Medicine. She received her BS in zoology from the University of Wyoming and her doctorate in vision science and biology at the University of Waterloo. Her post-doctorate training in visual electrophysiology was completed with Dr. Neal Peachey at Loyola School of Medicine and Hines VA Hospital in Chicago and focused on biocompatibility of retinal prosthetics. Pardue's research interests are focused on developing treatments for people with vision loss.

Magali Saint-Geniez

Magali Saint-Geniez, PhD
Associate Professor of Ophthalmology
Harvard Medical School
Schepens Eye Research Institute
Boston, Mass.

Magali Saint-Geniez joined the Schepens Eye Research Institute of Mass. Eye and Ear in 2002 to complete her postdoctoral training in the laboratory of Dr. Patricia D’Amore. During her fellowship, she characterized the role of VEGF in ocular development and the maintenance of retinal homeostasis. Her current research program focuses on the characterization of novel molecular pathways involved in retinal degenerative pathologies such as age-related macular degeneration, retinal detachment, and proliferative vitreoretinopathy.

Marco Sales-Sanz

Marco Sales-Sanz, MD, PhD
Head of Oculoplastic and Orbital Surgery Unit
Hospital Universitario Ramón y Cajal
Madrid, Spain

Marco Sales-Sanz completed his Medical training in the Universidad Autónoma de Madrid and performed the residency in Ophthalmology at the Hospital Universitario Ramón y Cajal in Madrid, Spain. He began his training in oculoplastic surgery during the fourth grade of medical school as first assistant of his mother, Dr. Andrea Sanz, and continued it for the rest of medical school and the whole ophthalmology residency. He performed different observership in oculoplastic surgery in Brazil, Paris, Amsterdam and Seoul, and a Fellowship in craneo-facial surgery with Dr. Krastinova at Hôpital Fôch, Paris. He completed his PhD thesis with cum laude degree in 2010. He has a master’s degree in medical management and has participated in the Leadership Development Program from PAAO/AAO in 2017-2018. Sales-Sanz is head of the Oculoplastic and Orbital Surgery Unit at Hospital Universitario Ramón y Cajal, Madrid, assigned by the Ministry of Health as National Referral Centre for the National Health System for Orbital Tumors and Orbital Decompression for Graves Orbitopathy. He works in private practice in the Orbital and Oculoplastic Surgery Unit at IMO Madrid. He is also clinical professor at University of Alcala. Sales-Sanz is the current vice-president of the Spanish Ophthalmic and Orbital Plastic Surgery Society (SECPOO), current vocal for Oculoplastic Surgery of the Spanish Facial Plastic Surgery Society (SECPF), full member of the European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS) and member of the Spanish Society of Ophthalmology (SEO). He has published more than 25 indexed publications and 30 book chapters, most of them in the orbit and oculoplastic surgery fields.

Sarwat Salim

Sarwat Salim, MD, FACS
Director of Glaucoma Services, St. Elizabeth's Community Practice
Vice Chair for Clinical and Academic Affairs, Department of Ophthalmology
Professor
Tufts University School of Medicine
Boston, Mass.

Sarwat Salim is the director of Glaucoma Services and the St. Elizabeth’s Community Practice. She also serves as the vice chair for Clinical and Academic Affairs for the Department of Ophthalmology and is a professor at Tufts University School of Medicine. Her clinical focus areas are glaucoma and cataract surgery. Salim's research focus includes diagnostic and surgical aspects of glaucoma. 

Daisy Shu

Daisy Shu, PhD
Postdoctoral Researcher
Saint-Geniez Lab
Harvard Medical School
Boston, Mass.

Daisy Shu is a postdoc in the Saint-Geniez Lab, Harvard Medical School studying the role of mitochondria and cellular metabolism in retinal eye diseases. She is passionate about science communication and loves sharing her scientific research journey through social media on Instagram and Twitter. Shu has recently started blogging about tips in science, interviews with her favorite scientists and all things #scicomm.

Eduardo Silva

Eduardo Silva, MD, PhD, FEBO
Head, Department at CRI Ophthalmology
Hospital Dona Estefânia
Lisbon, Portugal

Eduardo Silva is the head of department atCRI Ophthalmology at Hospital Dona Estefânia in Lisbon, Portugal. He formally served as an assistant professor in ophthalmology at University of Coimbra in Coimbra, Portugal. His clinical expertise includes Pediatric Ophthalmology, Strabismus, Genetic eye diseases with a special interest in genetics of retinal dystrophies and developmental eye disorders.

Adriana Solano

Adriana Solano, MD
Pediatric Ophthalmology and Strabismus surgeon
Bogotá, Colombia

Adriana Solano is a pediatric ophthalmology and strabismus surgeon. She is also president of the Colombian Association of Pediatric Ophthalmology and Strabismus. Solano serves as well as an associate professor at Fundación Universitaria de Ciencias de la Salud, in Bogotá, Colombia.

Sruthi Srinivasan, PhD, BSOptom, FAAOSruthi Srinivasan
Clinical Development & Medical Affairs - Senior Project Lead, Ocular Health
Alcon
Georgia

Sruthi Srinivasan is a senior project lead for Ocular Health Clinical Development & Medical affairs at Alcon, where she has been since 2018. Previously, she was a research assistant professor and a senior clinical scientist at the Centre for Ocular Research and Education (CORE), School of Optometry and Vision Science, University of Waterloo, Canada. She has over 15 years of experience in the field of Dry Eye Research, published over 45 peer-reviewed articles and has lectured in several countries around the world.

Stephanie Watson

Stephanie Watson, BSc(Med), MBBS, PhD, FRANZCO
Save Sight Institute Faculty of Medicine and Health
The University of Sydney, Australia

Stephanie Watson is a clinician scientist appointed at the University of Sydney and Sydney Eye, Sydney Children's and Prince of Wales Hospitals. Known for her ground-breaking research in corneal therapies, she has over 210 publications, is invited to speak internationally and has raised over $10 million for her research programme. Data from Watson’s research has featured widely in Australian and international media, including in the New York Times, a Sydney Morning Herald article with reach of over 8.3 million and the film Vitamania. She contributes to policy as chair, Ophthalmic Research Institute of Australia, chair-elect to ARVO's Advocacy and Outreach Committee, expert advisor to the $150M Stem Cell Therapies Mission, and editor for the Cochrane Eyes and Vision Group. Watson was awarded the NSW Premier’s Prize for Leadership in Innovation, RANZCO Council lecture, first prize Medical Device Commercialization Training Program, ATP Innovations/NSW Office for Health and Medical Research and nominated for NSW Women of the Year and a Pride of Australia award. She also led her team to win the Best Health Innovation Product Idea, IDE group.

Ravaughn Williams

Ravaughn Williams, OD, MS, FAAO
Head, Clinical Development and Medical Affairs, Vision Care Franchise
Alcon
Texas

Ravaughn Williams is an optometrist who started working for Alcon right after her schooling at the Ohio State University and University of Houston. She has worked with Alcon for almost 14 years, and has progressively advanced in her scope of responsibility within the company. Her initial role at Alcon was as a clinical manager working on pharmaceutical products in dry eye and glaucoma. In this role, her primary responsibility was the execution of clinical trials. After five years, she transitioned to the surgical business in a clinical role of expanded scope and responsibility. In this role, she developed clinical strategies and designed clinical studies to gain regulatory approval of refractive lasers around the globe and to support the products while on the market. She also worked on intraocular lenses for cataract surgery and cataract equipment while in the surgical business. In Williams’ current role as head of Clinical Development and Medical Affairs, Vision Care, she leads a group of clinicians and scientists to develop clinical strategies and design clinical studies for regulatory approval and market support of Alcon’s contact lens portfolio. She has been in this role for almost two years and during this time, Williams and her team have contributed to two major product launches. Outside of work, she spends her time with family and friends, running and hiking.

Conference Program

View the Advance Conference program

Keynotes

Meet the Advance Conference keynote speakers Shawn Kanungo and Adrienne Scott, MD

Planning Committee

Meet the organizers of the Advance Conference